Page last updated: 2024-09-03

ra 642 and thromboxanes

ra 642 has been researched along with thromboxanes in 1 studies

Compound Research Comparison

Studies (ra 642)	Trials (ra 642)	Recent Studies (post-2010) (ra 642)	Studies (thromboxanes)	Trials (thromboxanes)	Recent Studies (post-2010) (thromboxanes)
20	0	0	3,202	149	199

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
De La Cruz, JP; García Campos, J; Mérida, F; Moreno, A; Sánchez de la Cuesta, F	1

Other Studies

1 other study(ies) available for ra 642 and thromboxanes

Article	Year
The pyrimido-pyrimidine derivatives, dipyridamole, mopidamol and RA-642, prevent from retinal vascular defects in experimental diabetes mellitus. Thrombosis research, 1996, Feb-01, Volume: 81, Issue:3 Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Dipyridamole; Epoprostenol; Male; Mopidamol; Neovascularization, Pathologic; Platelet Aggregation Inhibitors; Pyrimidines; Rats; Rats, Wistar; Thromboxanes	1996

Article

Year

The pyrimido-pyrimidine derivatives, dipyridamole, mopidamol and RA-642, prevent from retinal vascular defects in experimental diabetes mellitus.

Thrombosis research, 1996, Feb-01, Volume: 81, Issue:3

Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Dipyridamole; Epoprostenol; Male; Mopidamol; Neovascularization, Pathologic; Platelet Aggregation Inhibitors; Pyrimidines; Rats; Rats, Wistar; Thromboxanes

1996